EP4228598
TOPICAL FORMULATION COMPRISING SIROLIMUS
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.2.2022:
27.12.2023:
22702492.4
:
8.2.2042
:
TOPICAL FORMULATION COMPRISING SIROLIMUS
9.2.2022
27.12.2023
:
Sodha Pharma Consulting GmbH:
Finkenstrasse 11, 4104 Oberwil, CH
:
RAVINDRAKUMAR JIVAN, Sodha:
4104 Oberwil, CH
:
21172232:
5.5.2021:
EP
:
EP2022053113:
9.2.2022
:
A61K 9/06, A61K 9/14, A61K 31/436, A61P 17/00, A61P 35/00, A61K 47/10